| AMARIN CORP.ADR NEW 2025 |
| USA |
| Gesundheit |
| US0231114044 / A41557 |
| EH3 (Frankfurt) / AMRN (NASDAQ) |
| FRA:EH3, ETR:EH3, EH3:GR, NASDAQ:AMRN |
| - |
| https://www.amarincorp.co.. |
|
Amarin Corporation plc, a pharmaceutical company, ..
>Volltext.. |
| 281.76 Mio. EUR |
| 39.55 Mio. EUR |
| 196.14 Mio. EUR |
| -52.41 Mio. EUR |
| -74.28 Mio. EUR |
| -3.6 EUR |
| 5.82 Mio. EUR |
| 106.43 Mio. EUR |
| -18.87 Mio. EUR |
| 1.57 |
| -6.31% |
| -116.72% |
| - |
| - |
| - |
| - |
| AMARIN |
| 09.11.25 |
|